Overview: Initial test, a single-arm, open-label 1st-in-human proof-of-concept study in adults with distal radius fractures.

Novadip Biosciences’s bone grafting material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase Ib/IIa proof-of-concept study. The Belgian company’s NVDX3-CLN01 (NCT05987033) ...

The growing prevalence of orthopaedic conditions is boosting the market’s demand. South Korea’s bone graft and substitutes market is projected to expand at a compound annual growth rate of 4% ...

4, 2024 — Researchers have developed a revolutionary bone graft substitute inspired by coral which not only promotes faster healing but dissolves naturally in the body after the repair is ...

ALACHUA, Fla., February 3, 2025 - Evergen ("the Company"), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announces the ...

A bone marrow transplant process co-developed by investigators at the Johns Hopkins ... Following the transplant, they are ...

THIRUVANANTHAPURAM: Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has launched two innovative drug-eluting bone graft products. The products were unveiled by ...

OsteoFlo HydroFiber represents a disruptive advancement in orthopedic and spine surgery, offering surgeons a highly effective synthetic bone graft option that may enhance patient outcomes.

After six weeks in the hospital, Shandra passed away from tuberculosis, a complication linked to contaminated bone graft material used in her surgery. The tragic loss has left her family ...